journal article·2026-02

Additive Accelerated Meloxicam Release from Poly(Ester Urea) Fiber Implants for Acute Pain Management

Courtney S. Dziewior, Yize Li, Shaoyong Song, Anshu Agarwal, Kyle Coaker, Nicola G. Judge, Ru‐Rong Ji, Matthew L. Becker

Advanced Healthcare Materials· Volume 15· Issue 8
Publisher page

Abstract

ABSTRACT Current clinical pain management strategies rely heavily on orally prescribed opioids, especially oxycodone, as opposed to non‐steroidal anti‐inflammatory drugs (NSAIDs) or local anesthetics. Implanted devices that facilitate controlled, localized delivery of NSAIDs could sustain higher drug concentrations at the surgical site and extend pain management efficacy beyond oral or intravenous methods. Meloxicam‐loaded poly(ester urea) (PEU) nanofibers are fabricated with variations in polymer molecular mass, additives, additive loads, and substrate thickness to assess their respective influence on sustained meloxicam release. Nanofiber mats loaded with meloxicam and sodium bicarbonate demonstrated superior pain inhibition for three days over intraperitoneal (IP) and intramuscular (IM) injections of meloxicam in a murine tibial fracture pain model. Biopsies of muscle tissue surrounding the fracture, one day post‐treatment, possessed high meloxicam concentrations relative to plasma and significantly reduced Ptgs2 expression and COX‐2 inhibition. This work demonstrates the extended performance of local meloxicam‐loaded PEU implants with significant pain and inflammation suppression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Luminescence and Fluorescent Materials · Anesthesia and Pain Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry Duke University Durham North Carolina USA

Center for Translational Pain Medicine Department of Anesthesiology Duke University School of Medicine Durham North Carolina USA

Thomas Lord Department of Mechanical Engineering and Materials Science Duke University Durham North Carolina USA

Department of Biomedical Engineering Duke University Durham North Carolina USA

Funding

National Science Foundation · Congressionally Directed Medical Research Programs

References (76)

Show source-provided references
1. 10.1016/j.xcrm.2024.10178610.1016/j.xcrm.2024.101786 ↗
2. 10.2344/0003‐3006‐59.2.9010.2344/0003‐3006‐59.2.90 ↗
3. 10.1016/j.bcp.2020.11414710.1016/j.bcp.2020.114147 ↗
4. 10.1016/j.addr.2021.01.01910.1016/j.addr.2021.01.019 ↗
5. 10.1016/j.addr.2023.11495010.1016/j.addr.2023.114950 ↗
6. 10.1016/S1367‐5931(00)00227‐110.1016/S1367‐5931(00)00227‐1 ↗
7. 10.1021/acs.chemrev.5b0034610.1021/acs.chemrev.5b00346 ↗
8. 10.1016/j.jconrel.2015.09.01110.1016/j.jconrel.2015.09.011 ↗
9. 10.1016/j.jconrel.2011.11.03110.1016/j.jconrel.2011.11.031 ↗
10. 10.1038/s41467‐021‐21438‐310.1038/s41467‐021‐21438‐3 ↗
11. 10.1021/acs.biomac.3c0083210.1021/acs.biomac.3c00832 ↗
12. 10.1016/j.jconrel.2023.08.06110.1016/j.jconrel.2023.08.061 ↗
13. 10.1016/j.jconrel.2011.09.06410.1016/j.jconrel.2011.09.064 ↗
14. 10.1016/j.jconrel.2025.11365910.1016/j.jconrel.2025.113659 ↗
15. 10.1016/j.jconrel.2023.07.03410.1016/j.jconrel.2023.07.034 ↗
16. 10.1016/j.jconrel.2022.09.03110.1016/j.jconrel.2022.09.031 ↗
17. 10.1038/s41598‐020‐71129‐010.1038/s41598‐020‐71129‐0 ↗
18. 10.1016/j.jconrel.2021.01.03810.1016/j.jconrel.2021.01.038 ↗
19. 10.1038/s41467‐018‐04910‐510.1038/s41467‐018‐04910‐5 ↗
20. 10.1016/j.jconrel.2025.11359010.1016/j.jconrel.2025.113590 ↗
21. 10.1016/j.jconrel.2022.12.01910.1016/j.jconrel.2022.12.019 ↗
22. 10.1016/j.jconrel.2023.05.04910.1016/j.jconrel.2023.05.049 ↗
23. 10.1016/j.jconrel.2021.05.01010.1016/j.jconrel.2021.05.010 ↗
24. 10.1016/j.jconrel.2014.08.02410.1016/j.jconrel.2014.08.024 ↗
25. 10.1016/j.jconrel.2022.04.00410.1016/j.jconrel.2022.04.004 ↗
26. 10.1021/jacs.5c0325310.1021/jacs.5c03253 ↗
27. 10.1038/s41467‐023‐36330‐510.1038/s41467‐023‐36330‐5 ↗
28. 10.1021/jacs.3c0564510.1021/jacs.3c05645 ↗
29. 10.1016/j.jconrel.2024.10.05910.1016/j.jconrel.2024.10.059 ↗
30. 10.1021/nn100634r10.1021/nn100634r ↗
31. 10.1021/acsnano.4c1404110.1021/acsnano.4c14041 ↗
32. 10.1021/nn500704t10.1021/nn500704t ↗
33. 10.1021/acsnano.0c0452710.1021/acsnano.0c04527 ↗
34. 10.1002/adhm.20240211310.1002/adhm.202402113 ↗
35. 10.1002/adhm.20220295910.1002/adhm.202202959 ↗
36. 10.1002/adhm.20190117010.1002/adhm.201901170 ↗
37. 10.1016/j.jconrel.2020.11.05210.1016/j.jconrel.2020.11.052 ↗
38. 10.1002/adhm.20240280010.1002/adhm.202402800 ↗
39. 10.1016/j.jconrel.2024.09.04810.1016/j.jconrel.2024.09.048 ↗
40. 10.1016/j.jconrel.2023.07.02210.1016/j.jconrel.2023.07.022 ↗
41. 10.1002/adhm.20150099610.1002/adhm.201500996 ↗
42. 10.1016/j.progpolymsci.2024.10186610.1016/j.progpolymsci.2024.101866 ↗
43. 10.1016/j.biomaterials.2019.11939910.1016/j.biomaterials.2019.119399 ↗
44. 10.1021/acsbiomaterials.7b0092010.1021/acsbiomaterials.7b00920 ↗
45. 10.1021/acsbiomaterials.5b0016810.1021/acsbiomaterials.5b00168 ↗
46. 10.1021/acs.biomac.9b0158610.1021/acs.biomac.9b01586 ↗
47. 10.1016/j.biomaterials.2018.08.00310.1016/j.biomaterials.2018.08.003 ↗
48. 10.1021/acsami.4c0974210.1021/acsami.4c09742 ↗
49. 10.1021/acsami.6b0967610.1021/acsami.6b09676 ↗
50. 10.1016/j.aca.2023.34196310.1016/j.aca.2023.341963 ↗
51. 10.1021/bm501669u10.1021/bm501669u ↗
52. 10.1172/jci8088310.1172/jci80883 ↗
53. 10.1038/ncomms1253110.1038/ncomms12531 ↗
54. 10.3389/fphar.2018.0041210.3389/fphar.2018.00412 ↗
55. 10.1016/j.addr.2023.11485710.1016/j.addr.2023.114857 ↗
56. 10.1016/j.ijpharm.2025.12582210.1016/j.ijpharm.2025.125822 ↗
57. 10.1016/j.jconrel.2023.06.01610.1016/j.jconrel.2023.06.016 ↗
58. 10.1021/acs.molpharmaceut.4c0068610.1021/acs.molpharmaceut.4c00686 ↗
59. 10.1021/acsbiomaterials.0c0122810.1021/acsbiomaterials.0c01228 ↗
60. 10.3390/pharmaceutics1403061410.3390/pharmaceutics14030614 ↗
61. 10.1021/acs.molpharmaceut.0c0108910.1021/acs.molpharmaceut.0c01089 ↗
62. 10.1016/j.colsurfa.2017.04.08010.1016/j.colsurfa.2017.04.080 ↗
63. 10.1016/j.polymer.2013.08.04410.1016/j.polymer.2013.08.044 ↗
64. 10.3791/6359010.3791/63590 ↗
65. 10.1016/j.ijpharm.2022.12163810.1016/j.ijpharm.2022.121638 ↗
66. 10.1007/s10439‐017‐1876‐710.1007/s10439‐017‐1876‐7 ↗
67. 10.1016/j.jconrel.2012.05.04910.1016/j.jconrel.2012.05.049 ↗
68. 10.1016/j.bone.2012.09.03710.1016/j.bone.2012.09.037 ↗
69. 10.1038/srep4616110.1038/srep46161 ↗
70. 10.3390/pharmaceutics1502063710.3390/pharmaceutics15020637 ↗
71. 10.3390/pharmaceutics1705067110.3390/pharmaceutics17050671 ↗
72. 10.3390/microorganisms1107166110.3390/microorganisms11071661 ↗
73. 10.1038/s41467‐024‐49146‐810.1038/s41467‐024‐49146‐8 ↗
74. 10.7150/ijbs.8649210.7150/ijbs.86492 ↗
75. 10.1002/jor.2106110.1002/jor.21061 ↗
76. 10.1186/s12974‐020‐1703‐110.1186/s12974‐020‐1703‐1 ↗